9 terminated. 9 Phase 1, 1 Phase 2.
| Phase | Trials | Status |
|---|---|---|
| Phase 1 | 9 | Terminated 9 |
| Phase 2 | 1 | Terminated 1 |
Follow Cellcept: new trials by email Literature Review of Cellcept trials Research Report on Cellcept
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Chemotherapy in Patients With Relapsed Small Cell Lung Cancer in Combination With Allopurinol and MycoPhenolate (CLAMP Trial) Mycophenolate Mofetil, Allopurinol, Irinotecan - Small-cell Lung Cancer, Small Cell Lung Carcinoma | Phase 1 | Terminated | Washington University School of Medicine | 17 | 2023-02-27 | 2024-12-05 |
| Nonmyeloablative Conditioning and Transplantation for Patients With Refractory Systemic Lupus Erythematosus (SLE) Cyclophosphamide, Fludarabine, Tacrolimus - Lupus Erythematosus, Graft-versus-host Disease | Phase 1 / Phase 2 | Terminated | Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins | 1 | 2016-09-13 | 2019-10-02 |
| Nonmyeloablative Conditioning for Mismatched Hematopoietic Stem Cell Transplantation for Severe Sickle Cell Disease Alemtuzumab, Cyclophosphamide, Mycophenolate mofetil - Sickle Cell Disease | Phase 1 | Terminated | Washington University School of Medicine | 1 | 2016-04-26 | 2022-02-14 |
| Sirolimus and Mycophenolate Mofetil in Preventing GVHD in Patients With Hematologic Malignancies Undergoing HSCT Allogeneic Hematopoietic Stem Cell Transplantation, Laboratory Biomarker Analysis, Mycophenolate Mofetil - Adult Hodgkin Lymphoma, Adult Myelodysplastic Syndrome | Phase 1 | Terminated | Stanford University | 1 | 2016-02-01 | 2018-09-12 |
| Donor-Alloantigen-Reactive Regulatory T Cell (darTregs) in Liver Transplantation Anti-Thymocyte Globulin - Rabbit, darTreg Infusion, Everolimus - Liver Transplantation | Phase 1 | Terminated | National Institute of Allergy and Infectious Diseases (NIAID) | 15 | 2014-12-17 | 2020-09-22 |
| Lenalidomide After Donor Stem Cell Transplant and Bortezomib in Treating Patients With High Risk Multiple Myeloma fludarabine phosphate, total-body irradiation, nonmyeloablative allogeneic hematopoietic stem cell transplantation - Refractory Multiple Myeloma, Stage I Multiple Myeloma | Phase 1 | Terminated | Case Comprehensive Cancer Center | 8 | 2013-10-07 | 2017-02-17 |
| Iodine I 131 Monoclonal Antibody BC8, Fludarabine Phosphate, Cyclophosphamide, Total-Body Irradiation and Donor Bone Marrow Transplant in Treating Patients With Advanced Acute Myeloid Leukemia, Acute Lymphoblastic Leukemia, or High-Risk Myelodysplastic Syndrome Allogeneic Bone Marrow Transplantation, Cyclophosphamide, Fludarabine Phosphate - Acute Myeloid Leukemia Arising From Previous Myelodysplastic Syndrome, Adult Acute Lymphoblastic Leukemia in Remission | Phase 1 | Terminated | Fred Hutchinson Cancer Center | 26 | 2007-10-05 | 2023-02-09 |
| Cyclophosphamide, Antithymocyte Globulin, and Total-Body Irradiation in Treating Patients With Severe Aplastic Anemia Undergoing Umbilical Cord Blood Transplant total-body irradiation, cyclophosphamide, anti-thymocyte globulin - Aplastic Anemia | Phase 1 | Terminated | Fred Hutchinson Cancer Center | 30 | 2006-02-01 | 2011-01-05 |
| Rheumatoid Arthritis:Tolerance Induction by Mixed Chimerism Hematopoietic Stem Cell Transplantation, Fludarabine, Cyclophosphamide - Rheumatoid Arthritis | Phase 1 | Terminated | Northwestern University | 4 | 2002-09-01 | 2018-07-30 |
Anemia, Refractory, with Excess of Blasts (2) · Anemia, Aplastic (1) · Anemia, Sickle Cell (1) · Arthritis, Rheumatoid (1) · Blast Crisis (1) · Graft vs Host Disease (1) · Hodgkin Disease (1) · Leukemia, Myelogenous, Chronic, BCR-ABL Positive (1) · Leukemia, Myeloid, Acute (1) · Leukemia, Myeloid, Chronic-Phase (1) · Leukemia, Myelomonocytic, Chronic (1) · Lymphoma, Non-Hodgkin (1) · Multiple Myeloma (1) · Precursor Cell Lymphoblastic Leukemia-Lymphoma (1) · Primary Myelofibrosis (1)
Fred Hutchinson Cancer Center (2) · Washington University School of Medicine (2) · Case Comprehensive Cancer Center (1) · National Institute of Allergy and Infectious Diseases (NIAID) (1) · Northwestern University (1) · Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins (1) · Stanford University (1)
United States (9)
Ann Woolfrey (1) · Daniel Morgensztern, M.D. (1) · Hien K Liu, MD (1) · Jeffrey Bluestone, PhD (1) · Johnnie Orozco (1) · Mark A Schroeder, M.D. (1) · Qizhi Tang, PhD (1) · Rajni Agarwal-Hashmi (1) · Richard Burt, MD (1) · Sandy Feng, MD, PhD (1) · Sang-Mo Kang, MD, FACS (1)
P01CA044991 (1), P30CA043703 (1), R34AI095135 (1), U01AI110658 (1)